EyePoint Pharmaceuticals
EYPT
#8076
Rank
โ‚ฌ0.33 B
Marketcap
3,97ย โ‚ฌ
Share price
-7.21%
Change (1 day)
-61.55%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -โ‚ฌ0.24 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ7.61 Million. In 2025 the company made an earning of -โ‚ฌ0.2 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.24 Billion16.11%
2025 -โ‚ฌ0.2 Billion63.24%
2024 -โ‚ฌ0.13 Billion104.29%
2023 -โ‚ฌ59.63 Million-29.88%
2022 -โ‚ฌ85.03 Million87.2%
2021 -โ‚ฌ45.43 Million38.58%
2020 -โ‚ฌ32.78 Million-24.56%
2019 -โ‚ฌ43.45 Million
2017 -โ‚ฌ19.82 Million22.59%
2016 -โ‚ฌ16.17 Million-8.02%
2015 -โ‚ฌ17.58 Million-296.09%
2014 โ‚ฌ8.96 M-174.02%
2013 -โ‚ฌ12.11 Million37.42%
2012 -โ‚ฌ8.81 Million-56.29%
2011 -โ‚ฌ20.16 Million-1062.38%
2010 โ‚ฌ2.09 M-250.43%
2009 -โ‚ฌ1.4 Million-89.5%
2008 -โ‚ฌ13.27 Million
2005 -โ‚ฌ8.18 Million56.99%
2004 -โ‚ฌ5.21 Million73.7%
2003 -โ‚ฌ3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.86 Million-99.20% Bahamas
NRC Health
NRC
โ‚ฌ16.83 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA